Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The FDA on May 4 approved Novartis' combination therapy to treat an aggressive form of thyroid cancer.
Wilson-Cook Medical on May 7 earned FDA clearance for its product Hemospray, which is designed to help control bleeding in the gastrointestinal tract.
The president of Regional Health Rapid City (S.D.) Hospital said the hospital is taking additional steps to ensure its medical waste is being disposed of properly after city officials alleged last week the institution has continued to dump medical waste…
A Maine bill that aims to increase drug pricing transparency became law on April 30, according to a STAT report.
Facing ongoing pressure to reduce costs, hospitals and health systems are looking more closely at their supply chains as a source of significant, additional savings.
Melissa Laber, SVP of OptiFreight® Logistics, a Cardinal Health company
The FDA approved Novartis' cell therapy Kymriah to treat an additional type of blood cancer, the drugmaker announced May 1.
Regeneron Pharmaceuticals and Sanofi will lower the price of their cholesterol drug Praluent by up to $9,500 annually for Express Scripts customers. In return, Express Scripts will grant the drugmakers easier access to patients, the companies announced May 1.
The FDA cleared 3M's Attest Super Rapid Biological Indicator System for Steam, the company announced April 30.
St. Louis-based Ascension, the largest private nonprofit health system in the U.S., entered into a global supply chain joint venture with Ramsay Health Care Limited, a private hospital operator based in Sydney, Australia.
Amazon's retreat from drug distribution most captured readers' attention in April.